Team:Goettingen/Focus Groups
From 2012.igem.org
(Difference between revisions)
Line 588: | Line 588: | ||
- | < | + | <!-- sponsorbar --> |
- | < | + | <br><br> |
- | < | + | <table width=900> |
- | < | + | <tr><td> |
- | + | ||
- | < | + | <hr> |
- | < | + | <h2><span><b>Team Göttingen Sponsors and Supporter</b></span></h2> |
- | < | + | |
- | + | ||
- | < | + | |
- | + | ||
</td></tr> | </td></tr> | ||
</table> | </table> | ||
+ | |||
+ | <table width=900> | ||
+ | <tr> | ||
+ | <td><center><u>Head Sponsor:</u></center></td><td width=1></td> | ||
+ | <td><center><u>Premium Sponsor:</u></center></td><td width=1></td> | ||
+ | <td><center><u>Supporter:</u></center></td> | ||
+ | </tr> | ||
+ | |||
+ | <tr> | ||
+ | <td><a href="http://www.kws.com"><img width="150 px" src="http://www.patrickreinke.de/igem/kws.png"></a></td><td width=1; bgcolor=grey></td> | ||
+ | <td><a href="http://www.sartorius.com"><img width="250 px" src="http://www.patrickreinke.de/igem/sartorius.png"></a></td><td width=1; bgcolor=grey></td> | ||
+ | <td> | ||
+ | <img width="150 px" src="http://www.patrickreinke.de/igem/mpi.jpg"> | ||
+ | <img width="150 px" src="http://www.patrickreinke.de/igem/gzmb.jpg"> | ||
+ | <img width="150 px" src="http://www.patrickreinke.de/igem/eppendorf.jpg"> | ||
+ | </td> | ||
+ | </td> | ||
+ | </tr> | ||
+ | </table> | ||
+ | <!-- sponsorbar --> | ||
Revision as of 13:42, 23 August 2012
Language: English, Deutsch
|
Focus GroupsUnder process.. #1 - Selection / SwimmingUnder process... #2 - Speed ImprovementIn this group we focus on the improvement of E. coli swimming abilities. So far, we have been working with strain DH10B. #3 - Chemoreceptor LibraryIn this group, the main focus is to first clone the aspartate receptor TAR from E. coli under different strong constitutive promoters into vectors. After examination of effects overexpressing this chemotaxis receptor, the next challenge is to mutagenize this protein to receive a chemoreceptor library. Ideally, the specificity of the receptor becomes altered due to mutation of the ligand binding sites important for chemical binding. ↑ Return to top
|